DALLAS, Aug. 3, 2023 /PRNewswire/ — Havencrest Capital Management, a Dallas-based healthcare private equity firm, is pleased to announce the formation of its outpatient mental health platform, Deep Eddy Psychotherapy Management, LLC (“Deep Eddy”). Havencrest started the platform in April of 2022 and has since expanded with its acquisition of Dallas Counseling and Treatment Center Management, LLC (“DCTC”) in April of 2023 (collectively the “Company”).
Together, Deep Eddy and DCTC represent one of the largest outpatient mental health platforms in the state of Texas. Combined, the Company serves over 6,000 patients, with over 200 clinicians across 13 locations in Austin, Dallas, Houston and San Antonio, and the Company offers its services both in-person and remotely via telehealth throughout the state.
“We are very excited about our partnerships with Deep Eddy and DCTC, as there is a significant opportunity to expand access to high-quality, mental health care services,” commented Christopher W. Kersey, M.D., M.B.A., Founding Managing Partner of Havencrest Capital Management.
Dr. Charlotte Howard, founder of Deep Eddy, added, “My colleagues and I had many options when choosing a partner, but we believe Havencrest will best enable us to deliver on our mission to help change the way mental health is delivered and ultimately reach more patients and improve lives through our evidenced-based care model.”
Matt Shofner, Partner at Havencrest Capital Management, also commented, “With the rapidly-growing demand for mental health services across the country, outpatient mental health has been a subsector of immense interest for us. Our partnership with Deep Eddy and DCTC signifies our commitment to addressing this pressing need. Together, we are confident that we can create meaningful change and foster mental wellness in the communities we serve.”
ABOUT HAVENCREST CAPITAL MANAGEMENT
Dallas-based Havencrest Capital Management (“Havencrest”) is a healthcare-focused private equity fund with approximately $600M of assets under management (AUM). Havencrest comprises a leading team of investment professionals, Operating Partners and Senior Advisors, including many of the nation’s leading healthcare entrepreneurs, corporate executives and public policy experts.
With its unique approach to partnering with founder-owned healthcare companies with EBITDA between $5M – $15M, the Havencrest team has a successful track record in building leading companies that are changing the way healthcare is delivered in America. For additional information about Havencrest, please visit: www.havencrest.com.
In 2023, the M&A market for healthcare companies continues to build on STRATEGIC opportunities in the current market. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
